학술논문
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Document Type
Article
Author
Buchanan, S.G.; Hendle, J.; Lee, P.S.; Smith, C.R.; Bounaud, P.-Y.; Jessen, K.A.; Tang, C.M.; Huser, N.H.; Felce, J.D.; Froning, K.J.; Peterman, M.C.; Aubol, B.E.; Gessert, S.F.; Sauder, J.M.; Schwinn, K.D.; Russell, M.; Rooney, I.A.; Leon, B.C.; Do, T.H.; Sprengeler, P.A.; Thompson, D.A.; Smyth, L.; Pelletier, L.A.; Atwell, S.; Wasserman, S.R.; Emtage, S.; Burley, S.K.; Reich, S.H.; Adams, J.; Blaney, J.M.; Holme, K.
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, December 2009, 8(12):3181-3190)
Subject
Language
English
ISSN
15357163